Granted Patent
B2
US 7,772,429 · App. 11/690,993 · Granted Aug 10, 2010
Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use
Assignee:
Sanofi-Aventis Deutschland GmbH
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to the compound of the formula 1 and to its physiologically acceptable salts. The compound is suitable, for example, as a hypolipidemic.
Claims (1)
1. A compound of formula I
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 19, 2010
From: JAEHNE, GERHARD; FRICK, WENDELIN; LINDENSCHMIDT, ANDREAS; HEUER, HUBERT; SCHAEFER, HANS-LUDWIG; KRAMER, WERNER; GALIA, ERIC; GLOMBIK, HEINER; FLOHR, STEFANIE
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 024407/0195 →
CHANGE OF NAME
Recorded May 19, 2010
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 024407/0212 →
Priority Claims (1)
DE 103 14 610
· Apr 1, 2003
· national
Continuity (2)